Showing results (211-220 of 301) with videos related to
Sort By:
Pageof 31
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 8, 2019
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional datasetKoki Nakanishi, Mitsuro Kanda, Seiji Ito, et al.Journal of Gastric Cancer|April 10, 2020
Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset AnalysisKeizo Fujita, Mitsuro Kanda, Seiji Ito, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 22, 2024
Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional datasetKoki Nakanishi, Mitsuro Kanda, Seiji Ito, et al.Digestive Surgery|March 7, 2019
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution DatasetMasahiro Sasahara, Mitsuro Kanda, Seiji Ito, et al.Cancer Chemotherapy and Pharmacology|March 1, 2014
The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancerGoro Nakayama, Chie Tanaka, Keisuke Uehara, et al.Digestive Surgery|April 29, 2020
Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional DatasetMichita Shoka, Mitsuro Kanda, Seiji Ito, et al.World Journal of Surgery|September 26, 2019
Tumor size ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution DatasetMasayuki Tsutsuyama, Mitsuro Kanda, Seiji Ito, et al.International Journal of Clinical Oncology|September 23, 2019
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)Norifumi Hattori, Goro Nakayama, Keisuke Uehara, et al.World Journal of Surgery|November 1, 2018
Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional DatasetYuki Ito, Mitsuro Kanda, Seiji Ito, et al.Oncogene|July 31, 2021
Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cellsMitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, et al.Pageof 31